XML 73 R61.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Investments - MedicBeacon Narrative (Details) - MediBeacon Inc. - USD ($) | 1 Months Ended | 3 Months Ended |  |
--- | --- | --- | --- | ---
Apr. 30, 2024 | Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022
Schedule of Equity Method Investments [Line Items] |  |  |  |  |
Beneficial ownership percentage |  | 46.00% |  |  |
Huadong |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |
Beneficial ownership percentage |  |  | 46.20% |  | 47.20%
Life Sciences |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |
Equity method investments |  | $ 0 |  | $ 0 |
Interest income |  | 300,000 | $ 100,000 |  |
Gain on sale of investment |  |  | 3,800,000 |  |
Realized loss, equity issuance |  |  | $ 3,800,000 |  |
Cumulative unrecognized loss on equity method investments |  | 8,700,000 |  |  |
Notes Receivable | Life Sciences |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |
Notes receivable, face amount |  | $ 1,200,000 |  |  |
Notes receivable interest rate, percentage |  | 12.00% |  |  |
Notes receivable |  | $ 10,900,000 |  |  |
Realized loss |  | $ 1,200,000 |  |  |
Notes Receivable | Life Sciences | Subsequent Event |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |
Notes receivable, face amount | $ 1,100,000 |  |  |  |
Notes receivable interest rate, percentage | 12.00% |  |  |  |
Notes receivable term | 3 years |  |  |  |

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(10)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of interest income earned from interest bearing assets classified as other. + References No definition available. + Details
Name: | us-gaap_InterestIncomeOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cumulative Unrecognized Gain (Loss) On Equity Method Investments + References No definition available. + Details
Name: | vate_CumulativeUnrecognizedGainLossOnEquityMethodInvestments
Namespace Prefix: | vate_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Method Investment, Realized Gain (Loss) + References No definition available. + Details
Name: | vate_EquityMethodInvestmentRealizedGainLoss
Namespace Prefix: | vate_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Notes Receivable + References No definition available. + Details
Name: | vate_NotesReceivable
Namespace Prefix: | vate_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Notes Receivable, Face Amount + References No definition available. + Details
Name: | vate_NotesReceivableFaceAmount
Namespace Prefix: | vate_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Notes Receivable, Interest Rate, Stated Percentage + References No definition available. + Details
Name: | vate_NotesReceivableInterestRateStatedPercentage
Namespace Prefix: | vate_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Notes Receivable, Term + References No definition available. + Details
Name: | vate_NotesReceivableTerm
Namespace Prefix: | vate_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Realized Gain (Loss), Equity Method Investments, Equity Issuance + References No definition available. + Details
Name: | vate_RealizedGainLossEquityMethodInvestmentsEquityIssuance
Namespace Prefix: | vate_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Realized Loss, Equity Method Investments, Equity Issuance + References No definition available. + Details
Name: | vate_RealizedLossEquityMethodInvestmentsEquityIssuance
Namespace Prefix: | vate_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vate_MediBeaconIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=vate_HuadongMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=vate_LifeSciencesSegmentPansendMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |